Abstract
Diabetic retinopathy (DR) is the most common complication in patients with diabetes, and screening for sight-threatening end-stages is indicated to avoid severe visual loss. Screening of DR is nationally implemented in Denmark according to evidence-based national guidelines, which includes the use of individualised screening intervals. Treatment is indicated for proliferative DR and diabetic macular oedema, and treatment modalities include retinal laser therapy, intravitreal angiostatic therapy, and vitrectomy. In this review, we summarise the current guidelines for screening and treatment of DR in Denmark.
Translated title of the contribution | Diabetic retinopathy |
---|---|
Original language | Danish |
Article number | V04240246 |
Journal | Ugeskrift for Læger |
Volume | 187 |
Issue number | 2 |
ISSN | 0041-5782 |
DOIs | |
Publication status | Published - 20. Jan 2025 |